VIRP Virbac SA

Virbac : Declaration of the number of shares and voting rights 09/2024

Virbac : Declaration of the number of shares and voting rights 09/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

Information on the total number of voting rights and of shares representing the share capital

(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité

des Marchés Financiers)

Quotation place: Euronext Paris

Compartiment A

ISIN code: FR0000031577

DateTotal number of shares representing the share capitalTotal number of voting rights
September, 30 20248 390 660Gross total of voting rights : 12 708 271
Net total* of voting rights : 12 692 205

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

VIRBAC: Shaping the future of animal health

NYSE Euronext - Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP

Corporate Finance: tel. 33 4 92 08 71 32 / Email:

Website:

Attachment



EN
03/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Virbac SA

 PRESS RELEASE

Virbac : Declaration of the number of shares and voting rights 09/2024

Virbac : Declaration of the number of shares and voting rights 09/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20248 390 660Gross total of voting rights : 12 708 271Net total* of voting rights : 12 692...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

Virbac : Webcast feedback: H1 ahead of guidance and management confide...

>Confidence and visibility signalled by management - During its webcast, management underscored market share gains and its regular outperformance of the veterinary market. Our key takeaways are:1/ 2024 guidance is maintained (operating margin 2024E:16%) despite H1 results that topped consensus expectations: it seems cautious in our view, as we indicated yesterday morning (see our First Take), but the CFO highlighted weaker growth in H2 and historic seasonality (w...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

Virbac : Feedback webcast : S1 en avance sur la guidance et confiance ...

>Sérénité et visibilité affichée par le management - Lors de son webcast, le management a souligné les gains de parts de marché et sa surperformance régulière du marché vétérinaire. Nous retenons surtout :1/ La guidance 2024 est maintenue (MOP 24e :16%) malgré un S1 meilleure qu’attendu par le consensus : elle nous semble prudente comme indiqué hier matin (relire notre commentaire), mais le CFO a fait valoir une croissance moindre au S2 et la saisonnalité histori...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch